Abemaciclib trials for Hormone Receptor Positive HER-2 Negative Breast Cancer

Q: How many trials study Abemaciclib for Hormone Receptor Positive HER-2 Negative Breast Cancer?

3 recruiting trials study Abemaciclib in trials listing Hormone Receptor Positive HER-2 Negative Breast Cancer in our tracked data. This is not a statement that it treats the condition.

All Abemaciclib trials · All Hormone Receptor Positive HER-2 Negative Breast Cancer trials

Recruiting trials

Phase breakdown

Phase 1 2Phase 2 2Not applicable 1

Recruiting trials studying Abemaciclib for Hormone Receptor Positive HER-2 Negative Breast Cancer

Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
NCT05573126 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Female · 14 locations
Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
NCT06805812 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 24 locations
VS-6766+Abema+Fulv in Met HR+/HER- BC
NCT05608252 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations

Common questions

How many trials study Abemaciclib for Hormone Receptor Positive HER-2 Negative Breast Cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.